ThromboGenics Struggles to Find Patients for Phase II Eye Disease Trial Post author:Sam Post published:December 7, 2017 Post category:BioPharma Resources redirected to progress new drug candidates to clinic in H1 2018. Source: BioSpace You Might Also Like Pharma Giant Bristol-Myers Squibb Plans Layoffs, Effective Oct. 6 August 9, 2017 Adocia Announces First Quarter 2017 Financial Results April 17, 2017 Johnson & Johnson Hosts 'Shark-Tank'-Like Competition and Crowned This Biotech Startup as Its Winner April 18, 2017
Johnson & Johnson Hosts 'Shark-Tank'-Like Competition and Crowned This Biotech Startup as Its Winner April 18, 2017
